Laurion Capital Management »

Tscan Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $353k 60k 5.85
2024-03-31 $2.9M 363k 7.94
2023-12-31 $352k 60k 5.83

More positions owned by Laurion Capital Management

NVIDIA Corporation Call Option (NVDA)
Advanced Micro Devices Call Option (AMD)
Meta Platforms Cl A Call Option (META)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
United States Steel Corporation (X)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Hess (HES)
Ansys (ANSS)
Discover Financial Services (DFS)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Broadcom Call Option (AVGO)
Bridgebio Pharma (BBIO)
Bank of America Corporation (BAC)

View all positions for Laurion Capital Management

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BlackRock
BlackRock
BVF
Baker Bros. Advisors
Vanguard Group
Propel Bio Management
Deer Management
Alphabet
Simplify Asset Management
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Stempoint Capital
DC Funds

View all funds holding Tscan Therapeutics